Aspergillus sensitization in non-smokers versus smokers with chronic obstructive pulmonary disease.
作者信息
Muthu Valliappan, Kumar Ravinish, Prasad Kuruswamy Thurai, Sehgal Inderpaul Singh, Dhooria Sahajal, Soundappan Kathirvel, Rudramurthy Shivaprakash Mandya, Chakrabarti Arunaloke, Aggarwal Ashutosh N, Agarwal Ritesh
机构信息
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
RK and VM contributed equally to the manuscript and are the joint first authors. E-mail:
出版信息
Lung India. 2024 Sep 1;41(5):387-391. doi: 10.4103/lungindia.lungindia_175_24. Epub 2024 Aug 31.
Abstract
摘要
相似文献
1
Aspergillus sensitization in non-smokers versus smokers with chronic obstructive pulmonary disease.非吸烟者与患有慢性阻塞性肺疾病的吸烟者中的曲霉致敏情况。
Lung India. 2024 Sep 1;41(5):387-391. doi: 10.4103/lungindia.lungindia_175_24. Epub 2024 Aug 31.
2
Aspergillus sensitisation in bidi smokers with and without chronic obstructive lung disease.有和无慢性阻塞性肺疾病的比迪烟吸烟者中的曲霉致敏情况。
Mycoses. 2017 Jun;60(6):381-386. doi: 10.1111/myc.12605. Epub 2017 Jan 31.
3
[Expert consensus on the diagnosis and treatment of pulmonary aspergillosis in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者肺曲霉病诊断和治疗专家共识]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Jul 12;47(7):604-622. doi: 10.3760/cma.j.cn112147-20231228-00399.
4
Hospital readmissions with exacerbation of obstructive pulmonary disease in illicit drug smokers.非法药物吸烟者因慢性阻塞性肺疾病急性加重而再次入院的情况。
Lung. 2014 Oct;192(5):669-73. doi: 10.1007/s00408-014-9632-3. Epub 2014 Aug 6.
5
[Survival of patients with end-stage chronic obstructive pulmonary disease in relation to smoking habits].[终末期慢性阻塞性肺疾病患者的生存与吸烟习惯的关系]
Med Pregl. 2012 Mar-Apr;65(3-4):146-51. doi: 10.2298/mpns1204146t.
6
Association of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokers.当前吸烟与慢性阻塞性肺疾病及无症状吸烟者气道炎症的关联。
Respir Res. 2005 Apr 25;6(1):38. doi: 10.1186/1465-9921-6-38.
7
Smoking Cessation Among U.S. Adult Smokers With and Without Chronic Obstructive Pulmonary Disease, 2018.2018 年美国有和没有慢性阻塞性肺疾病的成年吸烟者戒烟情况。
Am J Prev Med. 2022 Apr;62(4):492-502. doi: 10.1016/j.amepre.2021.12.001. Epub 2022 Feb 2.
8
Carotid Artery Stiffness is Associated With Cognitive Performance in Former Smokers With and Without Chronic Obstructive Pulmonary Disease.颈动脉僵硬与有和无慢性阻塞性肺疾病的戒烟者认知表现相关。
J Am Heart Assoc. 2020 May 5;9(9):e014862. doi: 10.1161/JAHA.119.014862. Epub 2020 Apr 26.
9
Different patterns of lung sirtuin expression in smokers with and without chronic obstructive pulmonary disease.吸烟者中慢性阻塞性肺疾病患者与非患者肺组织沉默调节蛋白表达的不同模式。
Medicina (Kaunas). 2012;48(10):552-7.
10
Increased levels of inflammatory biomarker CX3CL1 in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者中炎症生物标志物 CX3CL1 水平升高。
Cytokine. 2020 Feb;126:154881. doi: 10.1016/j.cyto.2019.154881. Epub 2019 Oct 16.
本文引用的文献
1
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.修订的 ISHAM-ABPA 工作组临床实践指南，用于诊断、分类和治疗变应性支气管肺曲霉病/真菌病。
Eur Respir J. 2024 Apr 4;63(4). doi: 10.1183/13993003.00061-2024. Print 2024 Apr.
2
Prevalence of Aspergillus Sensitization and Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma: A Systematic Review of Global Data.成人支气管哮喘患者中曲霉菌致敏和变应性支气管肺曲霉病的流行情况：全球数据的系统评价。
J Allergy Clin Immunol Pract. 2023 Jun;11(6):1734-1751.e3. doi: 10.1016/j.jaip.2023.04.009. Epub 2023 Apr 23.
3
Sensitisation to recombinant allergens and clinical outcomes in COPD.对重组变应原的致敏和 COPD 的临床结局。
Eur Respir J. 2023 Jan 6;61(1). doi: 10.1183/13993003.00507-2022. Print 2023 Jan.
4
Sample size calculation for prevalence studies using Scalex and ScalaR calculators.使用 Scalex 和 ScalaR 计算器进行流行率研究的样本量计算。
BMC Med Res Methodol. 2022 Jul 30;22(1):209. doi: 10.1186/s12874-022-01694-7.
5
Could cattle dung burning have contributed to the epidemic of COVID-19-associated mucormycosis in India? Results of an experimental aero-mycological study.牛粪燃烧是否导致了 COVID-19 相关毛霉菌病在印度的流行？一项实验性空气真菌学研究的结果。
Mycoses. 2022 Nov;65(11):1024-1029. doi: 10.1111/myc.13487. Epub 2022 Jul 7.
6
Evaluation of Simpler Criteria for Diagnosing Allergic Bronchopulmonary Aspergillosis Complicating Asthma.评价用于诊断哮喘并发变应性支气管肺曲霉病的简化标准。
Front Cell Infect Microbiol. 2022 Mar 25;12:861866. doi: 10.3389/fcimb.2022.861866. eCollection 2022.
7
Prevalence of chronic obstructive pulmonary disease in India: A systematic review and meta-analysis.印度慢性阻塞性肺疾病的患病率：一项系统评价和荟萃分析。
Lung India. 2021 Nov-Dec;38(6):506-513. doi: 10.4103/lungindia.lungindia_159_21.
8
Prevalence of COPD among population above 30 years in India: A systematic review and meta-analysis.印度 30 岁以上人群中 COPD 的患病率：系统评价和荟萃分析。
J Glob Health. 2021 Aug 21;11:04038. doi: 10.7189/jogh.11.04038. eCollection 2021.
9
Obstructive lung diseases and allergic bronchopulmonary aspergillosis.阻塞性肺疾病和变应性支气管肺曲霉病。
Curr Opin Pulm Med. 2021 Mar 1;27(2):105-112. doi: 10.1097/MCP.0000000000000755.
10
A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD.高风险气道真菌群落与 COPD 频繁恶化和死亡相关。
Eur Respir J. 2021 Mar 11;57(3). doi: 10.1183/13993003.02050-2020. Print 2021 Mar.
Zotero 插件